🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 8 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/05/2018 | 119,86 | 120,29 | 116,23 | 119,24 | -1,06% | 3,39% | 811.439 |
| 16/05/2018 | 116,51 | 121,29 | 114,44 | 120,52 | +4,22% | 5,87% | 1.014.218 |
| 15/05/2018 | 112,29 | 116,49 | 111,88 | 115,64 | +2,26% | 4,11% | 1.489.668 |
| 14/05/2018 | 111,70 | 113,46 | 111,56 | 113,09 | +1,73% | 1,70% | 537.165 |
| 11/05/2018 | 107,30 | 112,16 | 107,05 | 111,17 | +3,75% | 4,77% | 600.163 |
| 10/05/2018 | 105,74 | 107,65 | 102,61 | 107,15 | +1,64% | 4,76% | 504.785 |
| 09/05/2018 | 105,36 | 106,47 | 100,95 | 105,42 | +7,45% | 5,24% | 1.026.882 |
| 08/05/2018 | 96,77 | 100,19 | 96,77 | 98,12 | -0,11% | 3,54% | 297.357 |
| 07/05/2018 | 97,13 | 98,83 | 97,13 | 98,23 | +1,35% | 1,75% | 363.080 |
| 04/05/2018 | 93,66 | 97,70 | 93,09 | 96,92 | +3,05% | 4,92% | 275.556 |
| 03/05/2018 | 96,23 | 96,82 | 93,60 | 94,05 | -2,70% | 3,35% | 504.624 |
| 02/05/2018 | 97,85 | 98,86 | 96,41 | 96,66 | -1,28% | 2,51% | 247.022 |
| 01/05/2018 | 96,48 | 98,75 | 95,52 | 97,92 | +1,36% | 3,34% | 442.107 |
| 30/04/2018 | 98,46 | 99,58 | 95,28 | 96,60 | -1,68% | 4,37% | 537.807 |
| 27/04/2018 | 99,39 | 99,39 | 96,15 | 98,25 | -0,71% | 3,26% | 287.578 |
| 26/04/2018 | 96,63 | 99,21 | 96,52 | 98,95 | +2,52% | 2,79% | 337.432 |
| 25/04/2018 | 100,75 | 100,75 | 95,81 | 96,52 | -4,36% | 4,91% | 690.412 |
| 24/04/2018 | 104,47 | 104,80 | 100,47 | 100,92 | -3,26% | 4,14% | 486.190 |
| 23/04/2018 | 104,70 | 105,21 | 103,36 | 104,32 | +0,14% | 1,76% | 284.853 |
| 20/04/2018 | 104,84 | 105,32 | 103,66 | 104,17 | -0,96% | 1,59% | 375.102 |
| 19/04/2018 | 105,53 | 106,13 | 103,57 | 105,18 | -0,99% | 2,43% | 342.080 |
| 18/04/2018 | 106,70 | 107,34 | 104,64 | 106,23 | -0,45% | 2,54% | 280.365 |
| 17/04/2018 | 105,01 | 106,94 | 104,60 | 106,71 | +2,03% | 2,23% | 264.655 |
| 16/04/2018 | 103,91 | 105,18 | 103,40 | 104,59 | +1,20% | 1,72% | 223.138 |
| 13/04/2018 | 105,22 | 105,47 | 102,31 | 103,35 | -1,03% | 3,00% | 294.151 |
| 12/04/2018 | 103,81 | 105,07 | 102,58 | 104,43 | +1,30% | 2,40% | 281.647 |
| 11/04/2018 | 101,14 | 103,73 | 100,43 | 103,09 | +1,52% | 3,26% | 465.672 |
| 10/04/2018 | 99,61 | 101,91 | 98,16 | 101,55 | +2,93% | 3,76% | 899.764 |
| 09/04/2018 | 97,22 | 99,69 | 96,81 | 98,66 | +2,10% | 2,96% | 348.653 |
| 06/04/2018 | 97,85 | 98,85 | 96,39 | 96,63 | -1,89% | 2,52% | 343.683 |